Managed care and the impact of glaucoma.
Changes in the healthcare system, population demographics, and treatment alternatives have contributed to an emerging awareness of glaucoma among managed care organizations. Early diagnosis and treatment are essential to thwarting the personal and economic consequences of end-stage glaucoma. Despite recognition of the need for early intervention and therapy, the literature suggests a great need still exists for improvements in lowering intraocular pressure, managing appropriate follow-up, and improving adherence to current glaucoma medication regimens. As the elderly population continues to increase, these issues will intensify and present further problems for the healthcare system. The purpose of this introductory manuscript is to highlight the literature on the clinical and economic impact of glaucoma and its importance to the managed care community. The remainder of the supplement will focus on the current management of glaucoma and the potential role of neuroprotection in this patient population.
Reeder
Claiborne E
CE
Xcenda, 3270 Girardeau Ave, Columbia, SC 29204, USA. gene.reeder@xcenda.com
Franklin
Meg
M
Bramley
Thomas J
TJ
D000368:Aged; D005901:Glaucoma / Q000191:economics / Q000517:prevention & control*; D017048:Health Care Costs; D006801:Humans; D008329:Managed Care Programs; D008403:Mass Screening; D008875:Middle Aged; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D014481:United States